Summary of Key Information:

Nature of Filing / Announcement: Regulatory filing under SEBI LODR Regulation 30 - Outcome of Board Meeting regarding incorporation of subsidiaries

Date of Board Meeting / Approval: July 01, 2026

Meeting Time: Commenced at 10:30 a.m. IST and concluded at 11:30 a.m. IST

Corporate Actions:

New Subsidiary Approvals:

  • The Board approved incorporation of ANLON MEDICARE PRIVATE LIMITED
  • The Board approved incorporation of ANLON BIOLOGICS PRIVATE LIMITED

Investment Details for ANLON MEDICARE PRIVATE LIMITED:

  • Subscription method: Cash consideration
  • Investment amount: Up to ₹1,100,000 (Rupees Eleven Lakhs Only)
  • Shareholding: 55% of equity share capital
  • Number of shares: 1,10,000 equity shares of face value ₹10 each
  • Subscription price: At face value
  • Business purpose: Manufacturing surgical implants and medical devices to complement and expand existing pain management business

Investment Details for ANLON BIOLOGICS PRIVATE LIMITED:

  • Subscription method: Cash consideration
  • Investment amount: Up to ₹650,000 (Rupees Six Lakhs Fifty Thousand Only)
  • Shareholding: 65% of equity share capital
  • Number of shares: 65,000 equity shares of face value ₹10 each
  • Subscription price: At face value
  • Business purpose: Development and manufacture of peptides, biosimilars, biological compositions and allied products

Name Change Approval:

  • The Board approved changing the name of existing subsidiary from "REMEMBER INDIA HEALTH LINKS PRIVATE LIMITED" to "ANLON MEDICOS PRIVATE LIMITED"
  • Subject to approval from Ministry of Corporate Affairs (MCA)

Regulatory Framework:

  • Approved pursuant to Sections 2(87), 186 and other applicable provisions of the Companies Act, 2013
  • Compliance with SEBI Listing Regulations and SEBI Master Circular ref. no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

Approval Requirements:

  • Incorporation subject to receipt of all requisite approvals from Registrar of Companies and other regulatory/statutory/governmental authorities
  • Country of incorporation for both subsidiaries: India
  • Holding company for both subsidiaries: Anlon Healthcare Limited

Industry Classification:

  • Both new subsidiaries belong to the Pharmaceuticals industry